Price Brandon
Goodwin Biotechnology Inc, Plantation, FL 33313, USA.
IDrugs. 2003 May;6(5):442-5.
The Conference on Plant-Made Pharmaceuticals was an inaugural event organized by Molecular Farming Association Inc, a non-profit organization created in 2000 to support the emergence of plant-made biopharmaceuticals and plant-factory companies. The meeting was sponsored by the Government of Canada, the Gouvermement du Québec and the Société Générale de Financement, along with 20 companies involved in plant-made pharmaceuticals and related activities. Although there was very little discussion of new biopharmaceuticals under development with these systems, this was the first meeting where participants could survey the entire breadth of technologies and approaches that are being taken to produce biopharmaceuticals in transgenic plants. Participants also heard about the technical, manufacturing and regulatory issues confronting transgenic plant expression systems, as well as from 'new technology' companies that hav not previously presented in a public forum. There was a clear sense emerging from the meeting that the hurdles currently facing the industry will be overcome and that transgenic plant systems will eventually move into the mainstream of biopharmaceutical manufacturing technologies.
植物源制药会议是由分子农业协会有限公司组织的首次活动,该协会是2000年成立的非营利组织,旨在支持植物源生物制药和植物工厂公司的兴起。会议由加拿大政府、魁北克省政府和法国兴业银行资助,还有20家从事植物源制药及相关活动的公司参与。尽管很少讨论利用这些系统正在研发的新型生物制药,但这是与会者首次能够全面审视用于在转基因植物中生产生物制药的各种技术和方法。与会者还了解到转基因植物表达系统面临的技术、生产和监管问题,以及此前未在公共论坛上展示过的“新技术”公司的情况。会议明确显示,该行业目前面临的障碍将被克服,转基因植物系统最终将进入生物制药制造技术的主流。